Skip to main content

Table 2 Histologic diagnosis

From: Retrospective analyses of trends in pancreatic surgery: indications, operative techniques, and postoperative outcome of 1,120 pancreatic resections

  1994 to 2001 2002 to 2006 2007 to 2012
Malignoma    
  Ductal adenocarcinoma 81 (22.3%) 108 (35.4%) 191 (42.3%)
  Distal bile duct cancer 13 (3.6%) 29 (9.5%) 15 (3.3%)
  Ampullary carcinoma 25 (6.9%) 29 (9.5%) 34 (7.5%)
  Duodenal carcinoma 2 (0.6%) 9 (3.0%) 4 (0.9%)
  Pancreatic neuroendocrine tumor 6 (1.7%) 13 (4.3%) 29 (4.3%)
  Metastases 4 (1.1%) 5 (1.6%) 9 (2.0%)
Benign tumors    
  IPMN 0 (0%) 7 (2.3%) 35 (7.7%)
Chronic pancreatitis 204 (56.2%) 83 (27.2%) 78 (17.3%)
Others 28 (7.7%) 22 (7.2%) 57 (12.6%)
  1. Number (percentage). IPMN, intraductal papillary mucinous neoplasm.